Drug
Glucagon For
Glucagon For: highest development phase Phase 1, developed by Fresenius Kabi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Fresenius Kabi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Glucagon for Injection (Fresenius Kabi USA) NCT02086227 | Phase 1 | Hypoglycemia |
Latest
No recent events.
Follow Glucagon For on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.